Anixa Biosciences's market cap is currently ―. The company's EPS TTM is $-0.345; its P/E ratio is -8.90; Anixa Biosciences is scheduled to report earnings on March 8, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23
Income Statement	-
Total Revenue	-	-	-	$ 210.00K	-
Gross Profit	$ -3.61M	$ 5.40M	$ -2.84M	$ 210.00K	$ 2.56M
EBIT	$ -3.29M	$ -2.72M	$ -2.55M	$ 3.23M	$ -2.56M
EBITDA	$ -3.28M	$ -2.71M	$ -2.54M	$ 3.25M	$ -2.54M
Net Income Common Stockholders	$ -3.25M	$ -2.69M	$ -2.51M	$ 3.21M	$ -2.32M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 23.80M	$ 23.84M	$ 25.53M	$ 26.98M	$ 27.70M
Total Assets	$ 25.37M	$ 25.52M	$ 26.58M	$ 27.60M	$ 28.31M
Total Debt	$ 162.00K	$ 175.00K	$ 187.00K	$ 198.00K	$ 209.00K
Net Debt	$ -23.64M	$ -23.67M	$ -25.35M	$ -26.78M	$ -27.49M
Total Liabilities	$ 1.77M	$ 2.15M	$ 1.99M	$ 1.69M	$ 1.39M
Stockholders Equity	$ 24.61M	$ 24.34M	$ 25.52M	$ 26.81M	$ 27.79M
Cash Flow	-
Free Cash Flow	$ -2.31M	$ -1.97M	$ -1.45M	$ -807.00K	$ -1.99M
Operating Cash Flow	$ -2.31M	$ -1.97M	$ -1.45M	$ -807.00K	$ -1.99M
Investing Cash Flow	$ 129.00K	$ -593.00K	$ -980.00K	$ -3.44M	$ -585.00K
Financing Cash Flow	$ 2.26M	$ 279.00K	$ 3.00K	$ 81.00K	$ 3.00K

Currency in USD

Anixa Biosciences Earnings and Revenue History

Income Statement >

Anixa Biosciences Debt to Assets

Balance Sheet >

Anixa Biosciences Cash Flow

Cash Flow >

Anixa Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing